Triple
T22690446
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | larotrectinib |
E561035
|
entity |
| Predicate | requiresBiomarker |
P46427
|
FINISHED |
| Object | NTRK gene fusion |
—
|
LITERAL FINISHED |
How this triple was built (2 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: NTRK gene fusion | Statement: [larotrectinib, requiresBiomarker, NTRK gene fusion]
PD
Predicate disambiguation
gpt-5-mini-2025-08-07
Target predicate: requiresBiomarker Context triple: [larotrectinib, requiresBiomarker, NTRK gene fusion]
-
A.
usedAsBiomarkerFor
Indicates that one entity serves as a biomarker for another entity, typically signaling the presence, progression, or risk of a specific condition or biological state.
-
B.
diagnosticBiomarker
Indicates that one entity serves as a measurable biological indicator used to detect, confirm, or help diagnose a condition or disease in another entity.
-
C.
requiresAssessmentOf
chosen
Indicates that one entity necessitates an evaluation, review, or judgment to be performed on another entity before proceeding or fulfilling a condition.
-
D.
requiresMeasures
Indicates that one entity necessitates the implementation or presence of specific measures, actions, or safeguards in relation to another entity or situation.
-
E.
hasTargetDisease
Indicates that an entity (such as a treatment, study, or intervention) is directed toward, intended to affect, or primarily concerned with a specified disease.
- F. None of above.
Provenance (3 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69e2454d71b48190a1f80af9f82b6fcf |
completed | April 17, 2026, 2:35 p.m. |
| NER | Named-entity recognition | batch_69f1789a1fd08190bce5fa0babe695d3 |
completed | April 29, 2026, 3:18 a.m. |
| PD | Predicate disambiguation | batch_69ee62b2259c819091ed1387a748b9f3 |
completed | April 26, 2026, 7:08 p.m. |
Created at: April 17, 2026, 3:13 p.m.